TY - JOUR
T1 - Repeated-sprint training in hypoxia boosts up team-sport-specific repeated-sprint ability
T2 - 2-week vs 5-week training regimen
AU - Shi, Qingde
AU - Tong, Tomas K.
AU - Nie, Jinlei
AU - Tao, Dan
AU - Zhang, Haifeng
AU - Tan, Xiaoying
AU - Kong, Zhaowei
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
PY - 2023/12
Y1 - 2023/12
N2 - Purpose: To investigate (1) the boosting effects immediately and 4 weeks following 2-week, 6-session repeated-sprint training in hypoxia (RSH2-wk, n = 10) on the ability of team-sport players in performing repeated sprints (RSA) during a team-sport-specific intermittent exercise protocol (RSAIEP) by comparing with normoxic counterpart (CON2-wk, n = 12), and (2) the dose effects of the RSH by comparing the RSA alterations in RSH2-wk with those resulting from a 5-week, 15-session regimen (RSH5-wk, n = 10). Methods: Repeated-sprint training protocol consisted of 3 sets, 5 × 5-s all-out sprints on non-motorized treadmill interspersed with 25-s passive recovery under the hypoxia of 13.5% and normoxia, respectively. The within- (pre-, post-, 4-week post-intervention) and between- (RSH2-wk, RSH5-wk, CON2-wk) group differences in the performance of four sets of RSA tests held during the RSAIEP on the same treadmill were assessed. Results: In comparison with pre-intervention, RSA variables, particularly the mean velocity, horizontal force, and power output during the RSAIEP enhanced significantly immediate post RSH in RSH2-wk (5.1–13.7%), while trivially in CON2-wk (2.1–6.2%). Nevertheless, the enhanced RSA in RSH2-wk diminished 4 weeks after the RSH (− 3.17–0.37%). For the RSH5-wk, the enhancement of RSA immediately following the 5-week RSH (4.2–16.3%) did not differ from that of RSH2-wk, yet the enhanced RSA was well-maintained 4-week post-RSH (0.12–1.14%). Conclusions: Two-week and five-week RSH regimens could comparably boost up the effects of repeated-sprint training in normoxia, while dose effect detected on the RSA enhancement was minimal. Nevertheless, superior residual effects of the RSH on RSA appear to be associated with prolonged regimen.
AB - Purpose: To investigate (1) the boosting effects immediately and 4 weeks following 2-week, 6-session repeated-sprint training in hypoxia (RSH2-wk, n = 10) on the ability of team-sport players in performing repeated sprints (RSA) during a team-sport-specific intermittent exercise protocol (RSAIEP) by comparing with normoxic counterpart (CON2-wk, n = 12), and (2) the dose effects of the RSH by comparing the RSA alterations in RSH2-wk with those resulting from a 5-week, 15-session regimen (RSH5-wk, n = 10). Methods: Repeated-sprint training protocol consisted of 3 sets, 5 × 5-s all-out sprints on non-motorized treadmill interspersed with 25-s passive recovery under the hypoxia of 13.5% and normoxia, respectively. The within- (pre-, post-, 4-week post-intervention) and between- (RSH2-wk, RSH5-wk, CON2-wk) group differences in the performance of four sets of RSA tests held during the RSAIEP on the same treadmill were assessed. Results: In comparison with pre-intervention, RSA variables, particularly the mean velocity, horizontal force, and power output during the RSAIEP enhanced significantly immediate post RSH in RSH2-wk (5.1–13.7%), while trivially in CON2-wk (2.1–6.2%). Nevertheless, the enhanced RSA in RSH2-wk diminished 4 weeks after the RSH (− 3.17–0.37%). For the RSH5-wk, the enhancement of RSA immediately following the 5-week RSH (4.2–16.3%) did not differ from that of RSH2-wk, yet the enhanced RSA was well-maintained 4-week post-RSH (0.12–1.14%). Conclusions: Two-week and five-week RSH regimens could comparably boost up the effects of repeated-sprint training in normoxia, while dose effect detected on the RSA enhancement was minimal. Nevertheless, superior residual effects of the RSH on RSA appear to be associated with prolonged regimen.
KW - High-intensity interval training
KW - Intermittent hypoxic training
KW - Team sports
KW - Training volume
KW - Yo–Yo intermittent recovery test
UR - http://www.scopus.com/inward/record.url?scp=85162053741&partnerID=8YFLogxK
U2 - 10.1007/s00421-023-05252-x
DO - 10.1007/s00421-023-05252-x
M3 - Article
AN - SCOPUS:85162053741
SN - 1439-6319
VL - 123
SP - 2699
EP - 2710
JO - European Journal of Applied Physiology
JF - European Journal of Applied Physiology
IS - 12
ER -